Ustekinumab in the Management of Hidradenitis Suppurativa: A Retrospective Study

J Drugs Dermatol. 2022 Mar 1;21(3):319-320. doi: 10.36849/JDD.6298.

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by the formation of recurrent abscesses in apocrine-bearing areas. In advanced stages, chronic inflammation leads to sinus tract formation and cicatrization.

MeSH terms

  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Inflammation
  • Retrospective Studies
  • Skin
  • Ustekinumab* / therapeutic use

Substances

  • Ustekinumab